Literature DB >> 30177377

Quantitative structure-activity relationship analysis using deep learning based on a novel molecular image input technique.

Yoshihiro Uesawa1.   

Abstract

Quantitative structure-activity relationship (QSAR) analysis uses structural, quantum chemical, and physicochemical features calculated from molecular geometry as explanatory variables predicting physiological activity. Recently, deep learning based on advanced artificial neural networks has demonstrated excellent performance in the discipline of QSAR research. While it has properties of feature representation learning that directly calculate feature values from molecular structure, the use of this potential function is limited in QSAR modeling. The present study applied this function of feature representation learning to QSAR analysis by incorporating 360° images of molecular conformations into deep learning. Accordingly, I successfully constructed a highly versatile identification model for chemical compounds that induce mitochondrial membrane potential disruption with the external validation area under the receiver operating characteristic curve of ≥0.9.
Copyright © 2018 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Keywords:  Deep learning; In silico; Mitochondrial membrane potential disruption; Molecular imagery; Quantitative structure–activity relationship; Three-dimensional structure

Mesh:

Year:  2018        PMID: 30177377     DOI: 10.1016/j.bmcl.2018.08.032

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  12 in total

1.  Recent trends in artificial intelligence-driven identification and development of anti-neurodegenerative therapeutic agents.

Authors:  Kushagra Kashyap; Mohammad Imran Siddiqi
Journal:  Mol Divers       Date:  2021-07-19       Impact factor: 3.364

2.  Prediction Model with High-Performance Constitutive Androstane Receptor (CAR) Using DeepSnap-Deep Learning Approach from the Tox21 10K Compound Library.

Authors:  Yasunari Matsuzaka; Yoshihiro Uesawa
Journal:  Int J Mol Sci       Date:  2019-09-30       Impact factor: 5.923

3.  DeepSnap-Deep Learning Approach Predicts Progesterone Receptor Antagonist Activity With High Performance.

Authors:  Yasunari Matsuzaka; Yoshihiro Uesawa
Journal:  Front Bioeng Biotechnol       Date:  2020-01-22

4.  Prediction of pharmacological activities from chemical structures with graph convolutional neural networks.

Authors:  Miyuki Sakai; Kazuki Nagayasu; Norihiro Shibui; Chihiro Andoh; Kaito Takayama; Hisashi Shirakawa; Shuji Kaneko
Journal:  Sci Rep       Date:  2021-01-12       Impact factor: 4.379

5.  Molecular Image-Based Prediction Models of Nuclear Receptor Agonists and Antagonists Using the DeepSnap-Deep Learning Approach with the Tox21 10K Library.

Authors:  Yasunari Matsuzaka; Yoshihiro Uesawa
Journal:  Molecules       Date:  2020-06-15       Impact factor: 4.411

6.  Network-based piecewise linear regression for QSAR modelling.

Authors:  Jonathan Cardoso-Silva; Lazaros G Papageorgiou; Sophia Tsoka
Journal:  J Comput Aided Mol Des       Date:  2019-10-18       Impact factor: 3.686

7.  Prediction Model of Aryl Hydrocarbon Receptor Activation by a Novel QSAR Approach, DeepSnap-Deep Learning.

Authors:  Yasunari Matsuzaka; Takuomi Hosaka; Anna Ogaito; Kouichi Yoshinari; Yoshihiro Uesawa
Journal:  Molecules       Date:  2020-03-13       Impact factor: 4.411

8.  Novel coronavirus (COVID-19) diagnosis using computer vision and artificial intelligence techniques: a review.

Authors:  Anuja Bhargava; Atul Bansal
Journal:  Multimed Tools Appl       Date:  2021-03-03       Impact factor: 2.757

9.  Development of an adverse drug event network to predict drug toxicity.

Authors:  Qier Wu; Olivier Taboureau; Karine Audouze
Journal:  Curr Res Toxicol       Date:  2020-06-11

10.  Quantum algorithm for quicker clinical prognostic analysis: an application and experimental study using CT scan images of COVID-19 patients.

Authors:  Kinshuk Sengupta; Praveen Ranjan Srivastava
Journal:  BMC Med Inform Decis Mak       Date:  2021-07-30       Impact factor: 2.796

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.